vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and BRC Group Holdings, Inc. (RILY). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $188.3M, roughly 1.4× BRC Group Holdings, Inc.). BRC Group Holdings, Inc. runs the higher net margin — 47.9% vs 0.7%, a 47.2% gap on every dollar of revenue. On growth, HUTCHMED (China) Ltd posted the faster year-over-year revenue change (-16.5% vs -21.9%).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
HCM vs RILY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $188.3M |
| Net Profit | $2.0M | $90.3M |
| Gross Margin | 37.7% | 79.5% |
| Operating Margin | -13.2% | 32.3% |
| Net Margin | 0.7% | 47.9% |
| Revenue YoY | -16.5% | -21.9% |
| Net Profit YoY | -83.6% | 1710.8% |
| EPS (diluted) | $0.00 | $2.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $188.3M | ||
| Q3 25 | — | $215.3M | ||
| Q2 25 | $277.7M | $188.2M | ||
| Q1 25 | $324.5M | $197.2M | ||
| Q4 24 | — | $241.0M | ||
| Q3 24 | — | $225.5M | ||
| Q2 24 | $305.7M | $256.0M | ||
| Q1 24 | — | $263.4M |
| Q4 25 | $2.0M | $90.3M | ||
| Q3 25 | — | $91.1M | ||
| Q2 25 | $455.0M | $139.5M | ||
| Q1 25 | $11.9M | $-10.0M | ||
| Q4 24 | — | $-5.6M | ||
| Q3 24 | — | $-284.4M | ||
| Q2 24 | $25.8M | $-433.6M | ||
| Q1 24 | — | $-49.2M |
| Q4 25 | 37.7% | 79.5% | ||
| Q3 25 | — | 83.7% | ||
| Q2 25 | 0.1% | 81.3% | ||
| Q1 25 | 48.0% | 81.4% | ||
| Q4 24 | — | 79.8% | ||
| Q3 24 | — | 82.1% | ||
| Q2 24 | 41.1% | 84.5% | ||
| Q1 24 | — | 85.3% |
| Q4 25 | -13.2% | 32.3% | ||
| Q3 25 | — | 30.4% | ||
| Q2 25 | -1.3% | 5.7% | ||
| Q1 25 | -5.0% | -31.2% | ||
| Q4 24 | — | -69.2% | ||
| Q3 24 | — | -36.4% | ||
| Q2 24 | -9.0% | -90.8% | ||
| Q1 24 | — | -6.1% |
| Q4 25 | 0.7% | 47.9% | ||
| Q3 25 | — | 42.3% | ||
| Q2 25 | 163.8% | 74.1% | ||
| Q1 25 | 3.7% | -5.1% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | — | -126.1% | ||
| Q2 24 | 8.4% | -169.4% | ||
| Q1 24 | — | -18.7% |
| Q4 25 | $0.00 | $2.78 | ||
| Q3 25 | — | $2.91 | ||
| Q2 25 | $0.52 | $4.50 | ||
| Q1 25 | $0.01 | $-0.39 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | — | $-9.39 | ||
| Q2 24 | $0.03 | $-14.35 | ||
| Q1 24 | — | $-1.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $226.6M |
| Total DebtLower is stronger | $93.2M | $1.4B |
| Stockholders' EquityBook value | $1.2B | $-171.5M |
| Total Assets | $1.8B | $1.7B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $226.6M | ||
| Q3 25 | — | $184.2M | ||
| Q2 25 | $1.4B | $267.4M | ||
| Q1 25 | $836.1M | $138.3M | ||
| Q4 24 | — | $146.9M | ||
| Q3 24 | — | $159.2M | ||
| Q2 24 | $802.5M | $236.9M | ||
| Q1 24 | — | $190.7M |
| Q4 25 | $93.2M | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | $93.4M | $1.3B | ||
| Q1 25 | $82.8M | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $-171.5M | ||
| Q3 25 | — | $-260.5M | ||
| Q2 25 | $1.2B | $-351.7M | ||
| Q1 25 | $759.9M | $-496.8M | ||
| Q4 24 | — | $-488.2M | ||
| Q3 24 | — | $-497.6M | ||
| Q2 24 | $740.1M | $-218.3M | ||
| Q1 24 | — | $228.4M |
| Q4 25 | $1.8B | $1.7B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | $1.8B | $1.5B | ||
| Q1 25 | $1.3B | $1.5B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | $1.3B | $3.2B | ||
| Q1 24 | — | $5.0B |
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $26.2M |
| Free Cash FlowOCF − Capex | $3.4M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 1.8% | — |
| Cash ConversionOCF / Net Profit | 4.21× | 0.29× |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $26.2M | ||
| Q3 25 | — | $-60.6M | ||
| Q2 25 | $-72.9M | $-25.6M | ||
| Q1 25 | $40.3M | $184.0K | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | — | $19.5M | ||
| Q2 24 | $-39.8M | $111.5M | ||
| Q1 24 | — | $135.4M |
| Q4 25 | $3.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-82.2M | — | ||
| Q1 25 | $32.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-49.9M | — | ||
| Q1 24 | — | — |
| Q4 25 | 1.2% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -29.6% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -16.3% | — | ||
| Q1 24 | — | — |
| Q4 25 | 1.8% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | — | — |
| Q4 25 | 4.21× | 0.29× | ||
| Q3 25 | — | -0.66× | ||
| Q2 25 | -0.16× | -0.18× | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.54× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCM
Segment breakdown not available.
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
